Residual Effects of Sleep Medications Are Commonly Reported and Associated with Impaired Patient-Reported Outcomes among Insomnia Patients in the United States
Table 1
Respondent characteristics.
Current user
%
Age (Mean, SD)
52.06
12.7
Age (10-year brackets)
Under 25
27
1.7
25–34
148
9.2
35–44
256
16.0
45–54
429
26.7
55–64
472
29.4
65–74
238
14.8
75 and older
35
2.2
Female
1260
78.5%
Non-white
203
12.6%
Completed college
791
49.3%
Annual household income
Below $25k
356
22.2%
$25–<50k
397
24.7%
$50–<75k
281
17.5%
$75k and above
481
30.0%
Decline to answer
90
5.6%
Employed
778
48.5%
BMI (Mean, SD)
26.6
6.6
BMI (categories)
Underweight
39
2.4%
Normal
544
33.9%
Overweight
472
29.4%
Obese (up to 35)
248
15.5%
Obese (over 35)
200
12.5%
Decline to answer
102
6.4%
Alcohol use
1050
65.4%
Current smoker
387
24.1%
Exercise in previous month
1018
63.4%
Psychiatric comorbidities
Alcoholism
60
3.7%
GAD or SAD
510
31.8%
Depression
802
50.0%
Schizophrenia
169
10.5%
Bipolar disorder
170
10.6%
Fibromyalgia
221
13.8%
Diagnosing doctor
General Practitioner/Family Practitioner/Internist
1075
67.0
Psychiatrist
358
22.3
Sleep Specialist
103
6.4
Other
69
4.3
Prescribing doctor
General Practitioner/Family Practitioner/Internist
